0001683168-23-002562.txt : 20230421 0001683168-23-002562.hdr.sgml : 20230421 20230421075855 ACCESSION NUMBER: 0001683168-23-002562 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230419 FILED AS OF DATE: 20230421 DATE AS OF CHANGE: 20230421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gumulka Jerzy CENTRAL INDEX KEY: 0001793252 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39126 FILM NUMBER: 23834574 MAIL ADDRESS: STREET 1: C/O CNS PHARMACEUTICALS, INC. STREET 2: 2100 WEST LOOP SOUTH STE 900 CITY: HOUSTON STATE: TX ZIP: 77027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001729427 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822318545 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: 1-800-946-9185 MAIL ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 4 1 ownership.xml X0407 4 2023-04-19 0 0001729427 CNS Pharmaceuticals, Inc. CNSP 0001793252 Gumulka Jerzy C/O CNS PHARMACEUTICALS, INC. 100 WEST LOOP SOUTH, SUITE 900 HOUSTON TX 77027 1 0 0 0 0 Common Stock 2023-04-19 4 P 0 2500 1.70 A 9673 D /s/ Christopher Downs, Attorney-in-Fact 2023-04-21